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ABSTRACT
PATIENT RULE INDUCTION METHOD FOR SUBGROUP IDENTIFICATION
GIVEN CENSORED DATA
Patrick J. Trainor
April 10, 2014
The identification of subgroups in clinical studies is an important aspect of personalized medicine. In order to develop tailored therapeutics, the factors that characterize subgroups with differential prognosis, response to treatment, and incidence
of adverse events or toxicities must be elucidated. We present a generalization of a
statistical learning algorithm, Patient Rule Induction Method (PRIM), that is well
suited for this task given a right-censored time-to-event outcome measure. This
algorithm works to recursively partition a covariate space into mutually exclusive
boxes that can be utilized to define subgroups. Conceptually the algorithm is similar
to classification and regression trees but rather than satisfying the goal of minimizing
overall prediction error, PRIM works to find the extrema of the response surface. The
algorithm’s performance in prognostic subgroup identification is demonstrated with
simulation studies and a case study using data from the Framingham Heart Study.
We find that the algorithm has much utility as it provides a set of easy to interpret
rules that define subgroups with maximal (minimal) survival or differential response
to an intervention as measured by a survival outcome.

iii

TABLE OF CONTENTS
PAGE
ABSTRACT

iii

LIST OF TABLES

v

LIST OF FIGURES

vi

INTRODUCTION

1

PATIENT RULE INDUCTION METHOD

6

GENERALIZATION OF PRIM TO RIGHT-CENSORED DATA

10

SIMULATION STUDIES

14

FRAMINGHAM CASE STUDY

21

DISCUSSION

25

REFERENCES

27

CURRICULUM VITA

29

iv

LIST OF TABLES
TABLE

PAGE

1. Prognostic identification simulation study results

16

2. Framingham box induction steps

21

3. Framingham box 1

22

4. Framingham box 2

23

4. Framingham box 3

23

6. Comparison of boxes 1-5

24

7. Comparison of boxes 1-3

24

8. Comparison of boxes 1 and 2

24

v

LIST OF FIGURES
FIGURE

PAGE

1. Example candidate sub-boxes

6

2. Example peeling solution

7

3. Example pasting solution

8

4. Theoretical PRIM solution

17

5. View of projected data onto PRIM solution

18

vi

1

INTRODUCTION

The identification of subgroups in clinical studies is a task of critical importance to
field of personalized medicine. Tezak et al. (2010) define personalized medicine as
“providing the right intervention or therapy, at the right dose, for the right person,
at the right time, by understanding the individual’s biology.” In order to develop
tailored therapeutics, an understanding of factors influencing an individual’s disease
course and response to a treatment must be developed. We define predictive factors
as factors that can be used to predict whether an individual will respond to treatment
and prognostic factors as those that can be used to estimate an individual’s chance
of disease recovery or recurrence (NCI, 2014). The study of prognostic factors is
a common goal in epidemiology, while the study of predictive factors is mostly conducted in a pharmacological setting. Epidemiological studies, such as the Framingham
Heart Study discussed in this paper, furnish many examples in which prognostic
factors have been used to identify subgroups with better or worse prognosis than
the overall population. However, while it has been well established that there are
many factors that cause significant variability in the response to clinical therapeutics
and interventions, clinical studies in pharmacology and in a pharmaceutical setting
are rarely designed to elucidate such predictive factors. Clinical efficacy and safety
studies are typically designed to demonstrate an overall response to a therapeutic
or intervention and not to identify subgroups of responders or non-responders. Such
variability in responsiveness may lead to sub-par clinical and dosing guidelines, or may
lead to the “failure” of a clinical study to demonstrate an overall treatment effect,
when subpopulations of responders do exist. Cardiovascular medicine furnishes many
1

such examples. Activation of the drug clopidogrel has been shown to be dependent
on the presence of certain genetic polymorphisms which results in differential responsiveness as measured by the inhibition of platelet reactivity (Luchessi et al., 2013;
Frelinger et al., 2013). This phenomenon of differential responsiveness and variability
in rates of adverse events has been documented with other cardiovascular drugs such
as warfarin, amiodarone, β-blockers, and statins (Johnson, 2013; Janse et al.,1998).
The concept of personalized medicine hopes to characterize such differences as a
function of genetics, patient factors, family history, concomitant medications, and
concomitant diseases.
The prevailing methodology for identifying subgroups using predictive or prognostic factors in clinical studies has been a regression approach. In order to identify
factors that influence prognosis, researchers typically build multivariable regression
models and then use a significance based approach to identify the covariates that
influence a patient’s prognosis. Likewise, to identify predictive factors, researchers
typically build multivariable models that incorporate treatment by covariate interactions. If a treatment by covariate interaction term is deemed significant, then it is
concluded that the covariate is a predictive factor. There are significant flaws with
using a regression based approach such as this for subgroup identification. The most
fundamental is that the goal of regression modeling is to develop models that fit the
data well globally. Yet often a subgroup with better prognosis or enhanced response
to treatment is a “bump” in the response surface which may be smoothed out by
regression models. Consequently, we desire a methodology for finding bumps in a
response surface for prognostic or predictive subgroup identification. In this paper
we present a generalization of a statistical learning algorithm, Patient Rule Induction
Method (Friedman and Fisher, 1999), that is well suited for such a task. Our modified
algorithm has been tailored for finding subgroups given a right censored time-to-event
response variable, since this is a common outcome measure in clinical studies.

2

The layout of this paper is as follows: In section 2 we discuss the original formulation of the PRIM algorithm and why it is ideal for subgroup identification. We then
introduce our generalization of the algorithm for prognostic subgroup identification
given a right censored time-to-event response variable in section 3. We then present
a further generalization so that the algorithm can be used for predictive subgroup
identification. Section 4 details a simulation study that demonstrates the suitability
of the algorithm for prognostic subgroup identification. In section 5 we demonstrate
prognostic subgroup identification using the Framingham Heart Study data. Finally
we discuss our results and the algorithms suitability for subgroup identification in
section 6.

3

2

PATIENT RULE INDUCTION METHOD

While prognostic and predictive subgroup identification serve different purposes, the
goals of both analyses are equivalent. In prognostic subgroup identification, we want
to find the region of the covariate space (the set of all possible covariate values) in
which a response variable takes its maximum or minimum values. For example, if
the response variable is a time-to-event outcome measure, then prognostic subgroup
identification means finding the subgroup which has greatest (or worst) survival.
With predictive subgroup identification, we want to find the region of the covariate
space in which the difference in response is maximal between study arms. In the
context of a time-to-event outcome measure, we are trying to identify the subgroup
in which the difference in survival between intervention and control is greatest. In
either case, the object of subgroup identification is the identification of the region of
the covariate space in which the maxima of a response variable is found. The PRIM
algorithm was developed for such a task. The algorithm is similar to regression trees
(Segal, 1988) in that the covariate space is recursively partitioned using a binary
split criteria. However, while regression trees split nodes using the minimization of
the sum of squares between fitted and observed values of the response variable, the
PRIM algorithm uses a spit criteria designed to maximize the response variable in
one of the child nodes. The final solution given by the PRIM algorithm is a sequential
partitioning of the covariate space into disjoint regions with the goal that the response
variable takes its maximum in the first partition and then decreases monotonically
thereafter. The rules that define the individual partitions then can be used to define
subgroups.
4

In this section, Patient Rule Identification Method for a numerical response variable is presented as was originally detailed by Friedman and Fisher (1999). While
they developed PRIM methodology for categorical and continuous response variables,
a generalization to right-censored response variables is needed and is presented in
this paper. The covariate space can be written as an external direct product of input
variables: S = S1 × S2 × . . . × Sp . With such a formulation, xi,j ∈ Sj is the realization
of the jth covariate for the ith study subject. Thus, for a clinical study, data will be
of the form {xi , yi } where xi will be a length p vector of covariates for the ith subject
and yi will be a clinical response variable. In general the PRIM algorithm proceeds
by two subroutines (top-down peeling and bottom-up pasting). A single iteration
of both routines generates a partition of the covariate space with the object of the
partitioning being maximization of the response variable.

2.1

TOP-DOWN PEELING

The top down peeling process begins with a p-dimensional hypercube B1 = S that
covers all of the data. The top-down peeling algorithm then proceeds as follows:
Generate sub-boxes bj− = {x : xj < xjθ } and bj+ = {x : xj > xj(1−θ) } for each
continuous covariate j ∈ {1, 2, . . . , p}.
Generate sub-boxes bj,m = {x : xj 6= sm } for each m level of categorical
covariate j ∈ {1, 2, . . . , p}.
Generate set of sub-boxes C1 (b) = {bj− , bj+ , bj,m : j ∈ {1, 2, . . . , p}}.
Define C2 (b) = {b : b ∈ C1 (b) and ω(B1 − b) > ω0 } where ω(b) =
b).
If C2 (b) 6= ∅:
Choose b∗ = arg maxb∈C2 (b) ave{yi : xi ∈ B1 \ b}.
5

1
n

Pn

i=1

1(xi ∈

Update B1 ← B1 \ b∗ .
Else Stop.
In Figure 1 we illustrate how candidate sub-boxes are generated given two continuous covariates and a binary response variable. For covariates X1 and X2 we generate
two sub-boxes, one with the upper θ quantile of the data removed (bj+ ) and one with
the lower θ quantile of the data removed (bj −). Since the response variable is binary
in this case, we select b∗ to be removed from B1 according to the criteria that we
want to maximize the proportion of responders in B1 \ b∗ .

Figure 1: Example candidate sub-boxes for classification problem with two covariates
given θ = .1.
After selecting b∗ , B1 is updated, B1 ← B1 \b∗ , and then the peeling routine begins
a new iteration using the updated hypercube. The peeling routine continues until no
subsequent peeling steps can be taken without the empirical support of B1 falling
below a pre-specified level ω0 . This iterative procedure is illustrated in Figure 2.
6

Figure 2: Example peeling for classification problem with two covariates given θ = .1.

2.2

BOTTOM-UP PASTING

In order to improve upon the performance of the top-down peeling algorithm Friedman
and Fisher (1999) propose a second algorithm known as bottom-up pasting. This
algorithm proceeds as follows:
Generate sub-boxes bj− from the left boundary of B1 for variable j, to the φ
quantile to the left, and bj+ from the right boundary of B1 for variable j, to the
φ quantile to the right for continuous variables j ∈ {1, 2, . . . , p}.
Generate sub-boxes bj,m = {x : xj = sm } for each previously deleted m level
of categorical covariate j ∈ {1, 2, . . . , p}.
Generate set of sub-boxes C1 (b) = {bj− , bj+ , bj,m : j ∈ {1, 2, . . . , p}}.
Choose b∗ = arg maxb∈C2 (b) ave{yi : xi ∈ B1 ∪ b}.
If ave{yi : xi ∈ B1 ∪ b∗ } >> ave{yi : xi ∈ B1 }:

7

Update B1 ← B1 ∪ b∗
Else Stop.
An example pasting routine is depicted in Figure 3.

Figure 3: Example pasting for classification problem with two covariates.

2.3

COVERING

After the first iteration of the peeling and pasting procedures, the result is a hypercube
B ( S that was constructed with the goal of optimizing the mean of the response
variable y. The peeling and pasting routine is then repeated on the remaining data
belonging to S\B1 , yielding a new hypercube B2 . In this way a sequence of hypercubes
{B1 , B2 , . . . , BK } is generated that partitions the covariate space and ideally has the
property that ave{yi |xi ∈ B1 } > ave{yi |xi ∈ B2 } > . . . > ave{yi |xi ∈ BK }.

2.4

USING PRIM FOR SUBGROUP IDENTIFICATION

Provided that the sequence of hypercubes has the property that the mean of the
response variable is decreasing, then B1 is an estimate of the region of the covariate
8

space where the response variable takes its maximum values. As a concrete example,
if the response variable was level of low-density lipoprotein (LDL) then we can use
the rules that define the hypercube B1 in order to estimate the subgroup with the
highest levels of LDL. Since the rules were generated by an algorithm that iteratively
shaves off and possibly adjoins quantiles for the covariates, the rules that define B1
are cleanly specified. Using the LDL example, the rules defining membership in B1
might be: {i : sexi = male, 55 < agei < 65, BMIi > 27.8, SBPi > 150}.

9

3

GENERALIZATION OF PRIM
TO RIGHT-CENSORED DATA

The original formulation of the PRIM algorithm is well suited for either numerical
or categorical data. Given numerical data, the binary spit criteria utilized is the
maximization of the response variable estimated by calculating means in the child
nodes. For categorical data the binary split criteria is the maximization of the
probability of class membership estimated by calculating proportions in the child
nodes. Given instead a right-censored time-to-event response variable the study data
for the ith subject consists of {X i , (ti , δi )} where δi is a censoring indicator. To
generalize the PRIM algorithm to this type of data a suitable split criteria must be
selected. We propose using the Tarone-Ware class of test statistics (Tarone and Ware,
1977; Kalbfleisch and Prentice, 2002) as such a split criteria.

3.1

TARONE-WARE STATISTICS

In this section we present a brief discussion of the Tarone-Ware class of statistics. To
test for the equality of r failure distributions, F1 (t), F2 (t), . . . , Fr (t), the failure times
for the sample pooled over the r strata are ordered: t1 < t2 < . . . < tk . At time tj , dj
denotes the number of failures for the pooled sample and nj denotes the total number
of subjects from the pooled sample at risk at immediately prior to tj . Further, di,j
and ni,j denote the number of failures and number at risk priort to tj in the ith strata
where i ∈ {1, 2, . . . , r}. Then for each failure time in the pooled sample the data can
be arranged into 2 × r contingency tables:
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failures
survivors
at risk

strata 1

strata 2

...

strata r

d1,j

d2,j

...

dr,j

dj

n1,j − d1,j

n2,j − d2,j

...

nr,j − dr,j

nj − dj

n1,j

n2,j

...

nr,j

nj

With this formulation, the rank statistics form a r length vector, v = (v1 , v2 , . . . vr )T ,
with entries given by:
k
X



ni,j dj
vi =
W (tj ) di,j −
nj
j=1
where W (ti ) is a non-negative weight function described in the preceding paragraph.
The estimated covariance matrix of the rank statistics has the following entries:

k 
X
ni,j (nj − ni,j )dj (nj − dj )
2
Vi,i =
W (tj )
n2j (nj − 1)
j=1

k 
X
−ni,j nl,j dj (nj − dj )
2
Vi,l =
W (tj )
.
n2j (nj − 1)
j=1
To use a statistic from the Tarone-Ware class of statistics test to compare the
survival of the jth group with the lth group, j 6= l, the following test statistic can be
constructed (Klein and Moeschberger, 1997):
(vj − vl )
.
Zj,l = p
Vjj + Vll − 2Vjl
This test statistic follows a N (0, 1) distribution.

3.2

TARONE-WARE STATISTICS AS PRIM BINARY SPLIT
CRITERIA

In our simulation studies we used the weight function W (ti ) = 1, which reduces the
test statistic to the well known log-rank test statistic. To use PRIM with such a split
11

criteria, we propose the following top-down peeling algorithm:
Generate sub-boxes bj− = {x : xj < xjθ } and bj+ = {x : xj > xj(1−θ) } for each
continuous covariate j ∈ {1, 2, . . . , p}.
Generate sub-boxes bj,m = {x : xj 6= sm } for each m level of categorical
covariate j ∈ {1, 2, . . . , p}.
Generate set of sub-boxes C1 (b) = {bj− , bj+ , bj,m : j ∈ {1, 2, . . . , p}}.
Define C2 (b) = {b : b ∈ C1 (b) and ω(B1 − b) > ω0 } where ω(b) =

1
n

Pn

i=1

1(xi ∈

b).
If C2 (b) 6= ∅:
Compute ZB1 \b,B1 for all sub-boxes b.
Choose b∗ = arg maxb∈C2 (b) ZB1 \b,B1 .
Update B1 ← B1 \ b∗ .
Else Stop.
For the bottom-up pasting routine, we proceed similarly–the distinction between
a continuous response variable and a right-censored time-to-event variable being
computing ZB1 ∪b,B1 for all sub-boxes b and then pasting on the sub-box b∗ to B1
if it results in greater survival.

3.3

PROGNOSTIC VS. PREDICTIVE SUBGROUP IDENTIFICATION

As detailed thus far, using a Tarone-Ware statistic for a split criteria adapts PRIM
for finding subgroups with maximal survival in a clinical study. This is the goal of
prognostic subgroup identification. However, to adapt PRIM for predictive subgroup
12

identification with right-censored time-to-event variables, we need to modify the split
criteria even further. In this case we are searching for the region of the covariate
space in which the difference in survival between a treatment group and a control
group is maximal.
Generate sub-boxes bj− = {x : xj < xjθ } and bj+ = {x : xj > xj(1−θ) } for each
continuous covariate j ∈ {1, 2, . . . , p}.
Generate sub-boxes bj,m = {x : xj 6= sm } for each m level of categorical
covariate j ∈ {1, 2, . . . , p}.
Generate set of sub-boxes C1 (b) = {bj− , bj+ , bj,m : j ∈ {1, 2, . . . , p}}.
Define C2 (b) = {b : b ∈ C1 (b) and ω(B1 − b) > ω0 } where ω(b) =
b).
If C2 (b) 6= ∅:
Compute Ztreatment,control for all sub-boxes b.
Choose b∗ = arg maxb∈C2 (b) Ztreatment,control .
Update B1 ← B1 \ b∗ .
Else Stop.

13
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i=1

1(xi ∈

4

SIMULATION STUDIES

In order to evaluate the PRIM algorithm’s ability to find subgroups with best prognosis in a clinical study, we conducted simulation studies. For each of the simulated
study subjects we assumed both failure time and censoring time followed an exponential distribution, i.e. T ∼ exp(λ) and C ∼ exp(ξ). Then log(T ) ≡ − log(λ) + W ,
where W has an extreme value distribution with pdf f (w) = exp(w − ew ). So we
assume that each subject’s failure time has the same error distribution W . To create
proportional hazards we define λ(X) = λ0 exp(Xβ), where Xi = (X1,i , X2,i , . . . , Xi,p ),
a vector of covariate realizations for the ith subject and β = (β1 , β2 , . . . , βp ) denotes
pre-specified effects. We set out to evaluate weather the rules defining the hypercube
after one iteration of the PRIM algorithm behave in a predictable fashion. We
hypothesized that algorithm’s sensitivity and specificity in identifying subgroups with
best prognosis would increase with sample size, and decrease with increasing scale of
the error distribution. For n = 50, 100, 200 and 1000 and σ = 0.1, 0.5, 1.0 and 2.0 we
generated study data using the following procedure:
1. Generate random wi such that W follows an extreme value distribution with
scale parameter σ.
2. Generate random X1,i and X2,i so that each X follows a standard normal
distribution.
3. Specify effects β = (1, 1) and baseline hazard rate λ0 = 1/10.
4. Compute failure time ti for ith subject using log(ti ) = − log [λ0 exp(Xi β)]+wi .

14

5. Generate random censoring time ci for the ith subject subject such that C ∼
exp(1/20).
We then have data of the form {X i , (ti , δi )}. The peeling subroutine of the PRIM
algorithm was then conducted using algorithm parameters θ = 0.15 and ω0 = 0.1. At
the conclusion of the peeling subroutine we then should have a 2-dimensional box B1
that contains about 1/10 of the original data. Since the hazard for the ith subject is
specified by λ0 exp(Xi β), we expect that since Xβ ∼ N (0, 2), if a subject has X1 +X2
less than the 10% percentile of N (0, 2) then that subject should belong to B1 .

4.1

SIMULATION STUDY RESULTS

Results of the prognostic identification simulation study are shown in Table 1. As
expected, the algorithm’s sensitivity and specificity are inversely related to the scale
of the extreme value error distribution.

For error distribution scale parameters

σ = 2, 1, 0.5, it is confirmed that the algorithm’s sensitivity does increase with
increasing sample size. However, we do not observe this effect as the effect of the
error distribution on failure time becomes negligible (σ = 0.1).

15

Table 1: Prognostic identification simulation study
Sensitivity
Error dist. σ

2

1

0.5

0.1

Specificity

N

mean

sd

mean

sd

50

0.339

0.287

0.900

0.032

100

0.439

0.258

0.915

0.029

200

0.522

0.212

0.930

0.024

1000

0.633

0.084

0.958

0.009

50

0.492

0.298

0.907

0.037

100

0.572

0.218

0.928

0.024

200

0.633

0.150

0.942

0.017

1000

0.664

0.049

0.962

0.005

50

0.636

0.284

0.903

0.046

100

0.664

0.187

0.932

0.024

200

0.682

0.118

0.947

0.014

1000

0.674

0.042

0.963

0.005

50

0.766

0.216

0.889

0.062

100

0.755

0.151

0.925

0.034

200

0.727

0.100

0.945

0.018

1000

0.680

0.040

0.963

0.004

One possible explanation warranting exploration for this effect is that it is due to
the algorithm approximating level sets of a response variable with hyper-cubes instead
of geometric shapes that conform to the response variable surface. Figures 4 and 5
illustrate this fact. For both figures 1000 observations were randomly generated such
that two covariates X and Y follow a standard normal distribution. The observations
are plotted with their sum on a third axis. A blue plane is added at the 85% of the
sum X + Y . A theoretical PRIM peel solution is shown as a salmon plane. Figure 5 is
16

a rotation of Figure 4 illustrating the projection of the data above the 85% percentile
onto the theoretical PRIM solution. As can be seen, a portion of the data above
the 85th quantile fails to be captured in the PRIM solution, leading to diminished
sensitivity.

Figure 4: Theoretical PRIM solution to 85th quantile of X + Y approximation.
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Figure 5: View of X + Y projected onto the theoretical PRIM solution.
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5

FRAMINGHAM CASE STUDY

We utilized the PRIM algorithm for prognostic subgroup identification using a subset
of the Framingham Heart Study provided as a public use teaching dataset by the
National Heart, Lung, and Blood Institute. This renowned study has been carried on
for over 65 years and has contributed greatly to the understanding of cardiovascular
diseases and their risk factors (Mahmood et al., 2013). The data utilized consisted of
potential cardiovascular risk factors, disease markers, and time-to-event outcomes for
4,434 study subjects. We applied the PRIM algorithm peeling subroutine to the data
to induce 5 boxes consisting of roughly half of the data. The response variable was
the right censored time from first study examination to myocardial infarction. The
covariates we considered which all represent measurements taken at the first study
examination were:
• Sex (Male/Female)
• Total serum cholesterol (mg/dL)
• Age
• Systolic blood pressure (mmHg)
• Diastolic blood pressure (mmHg)
• Current smoker (Yes/No)
• Body mass index
• Currently prescribed blood pressure medications (Yes/No)
19

• Heart Rate
• Serum glucose (mg/dL)
• History of coronary heart disease (Yes/No)
We applied the algorithm with parameters θ = 0.15 and ω0 =

1
,
11−k

where k

indexes the sequence of boxes. In this way, each of the boxes should have roughly
1/10 of the total data. We then can use the rules defining each of the boxes to
define subgroups, for which we hypothesize that measures of survival will decrease
monotonically with the index of the boxes or equivalently the subgroups defined by
the boxes.

5.1

RESULTS OF FRAMINGHAM CASE STUDY

The results of applying the PRIM algorithm’s peeling subroutine to the Framingham
data are shown in Table 2 through Table 8. In Table 2, the covariates used in the
analysis and their contributions to the first three boxes induced by the algorithm are
presented. In the rightmost column the covariate is listed, followed by the covariate
type, (Factor=F, Numeric=Num), at which iteration during the peeling routine the
covariate was used as a split criteria, and the factor level or quantile that was deleted.
For example, from the table we see that in Box 1 “Previous CHD” is the first split
criteria utilized and that the factor level deleted is “Yes”. The next split criteria
used in the construction of Box 1 is the covariate “Sex” for which the level deleted is
“Male”. The first numeric covariate used as a split criteria (used as the fourth split)
is “Age” for which the upper quantile was removed. This covariate is again used as
a split criteria for the 8th split–again removing the upper quantile. Dashes are used
to denote that a covariate was not used as a split criteria in the construction of the
box.
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Table 2: Framingham box induction steps
Variable

Type

Box 1

Deleted

Box 2

Deleted

Box 3

Deleted

F

2

Male

2

Male

2

Male

Total Cholesterol

Num

6, 7

Upper

6

Upper

4

Upper

Age

Num

4, 8

Upper

4

Upper

-

-

Systolic BP

Num

5

Upper

5, 7, 8, 10, 11

Upper

5

Upper

Diastolic BP

Num

-

-

-

-

-

-

F

9

Yes

-

-

7

Yes

Num

-

-

-

-

-

-

F

3

Yes

3

Yes

3

Yes

Heart Rate

Num

-

-

-

-

-

-

Serum Glucose

Num

-

-

9

Upper

6

Upper

Previous CHD

F

1

Yes

1

Yes

1

Yes

Sex

Current Smoker
BMI
BP Meds

Table 3 then illustrates the rules defining the first box induced by the algorithm.
In this table, “Old Range” corresponds to the acceptable range of covariate values
before this box is induced. “New Range” corresponds to the new range of values
after the box has been induced. Covariates never used as split criteria have their
ranges omitted for interpretablity. A study subject has membership in this box if the
following requirements are met: Female, non-smoker, no history of coronary heart
disease, not taking blood pressure medication, total serum cholesterol between 135
and 253 mg/dL, age between 32 and 52 years old at enrolment, and systolic blood
pressure between 83.5 and 149.0 mmHg. Using this information we can define a
subgroup that we hypothesize will have the “best” prognosis in terms of survival.
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Table 3: Framingham box 1
Variable

Type

Old Range

New Range

F

M, F

F

Total Cholesterol

Num

113-696

135-253

Age

Num

32-70

32-52

Systolic BP

Num

83.5-295.0

83.5-149.0

Diastolic BP

Num

-

-

F

Y, N

N

Num

-

-

F

Y, N

N

Heart Rate

Num

-

-

Serum Glucose

Num

-

-

Previous CHD

F

Y, N

N

Sex

Current Smoker
BMI
BP Meds

Tables 4-5 provide rules defining the next two subgroups. We hypothesize that
survival will decrease monotonically with each following box induced.
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Table 4: Framingham box 2
Number

Variable

Type

Old Range

New Range

F

M, F

F

1

Sex

2

Total Cholesterol

Num

113-696

135-287

3

Age

Num

32-70

32-61

4

Systolic BP

Num

83.5-295.0

83.5-124.0

5

Diastolic BP

Num

-

-

6

Current Smoker

F

-

-

7

BMI

Num

-

-

8

BP Meds

F

Y, N

N

9

Heart Rate

Num

-

-

10

Serum Glucose

Num

40-394

47-89

11

Previous CHD

F

Y, N

N

Table 5: Framingham box 3
Number

Variable

Type

Old Range

New Range

F

M, F

F

1

Sex

2

Total Cholesterol

Num

113-696

143-302

3

Age

Num

-

-

4

Systolic BP

Num

83.5-295.0

85.5-164.0

5

Diastolic BP

Num

-

-

6

Current Smoker

F

Y, N

N

7

BMI

Num

-

-

8

BP Meds

F

Y, N

N

9

Heart Rate

Num

-

-

10

Serum Glucose

Num

40-394

45-97

11

Previous CHD

F

Y, N

N
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In Table 6 the first five boxes induced by the algorithm (covering roughly half of
the data) are compared using a log-rank test. As hypothesized the observed number
of events is monotonically increasing. A three way comparison of the first three boxes
and a two way comparison of just the first two boxes is shown in Tables 7 and 8,
respectively.
Table 6: Comparison of boxes 1-5
Box

N

Observed

Expected

p-value

1

409

4

30.6

2.24 ∗ 10−17

2

412

8

29.8

3

409

27

27

4

406

44

26

5

421

59

28.5

Table 7: Comparison of boxes 1-3
Box

N

Observed

Expected

p-value

1

409

4

13.7

8.69 ∗ 10−7

2

412

8

13.3

3

409

27

12

Table 8: Comparison of boxes 1 and 2
Box

N

Observed

Expected

p-value

1

409

4

6.08

0.23

2

412

8

5.92

24

6

DISCUSSION

In this paper we present how the PRIM algorithm can be used to identify subgroups
in clinical studies given a right-censored time-to-event response variable. We have
demonstrated how to apply this algorithm for prognostic subgroup identification,
and have explained how the algorithm could be further extended for use in predictive
subgroup identification.
Some of the advantages of using the PRIM algorithm for subgroup identification
are readily apparent from the simulation studies and Framingham case study. First,
the algorithm is well suited for the task of subgroup identification because it is
designed to find regions of the covariate space in which a response variable has
its extrema. This is an important concept as this is usually the goal of subgroup
identification–to find the subpopulation with the best (worst) prognosis, best (worse)
response to treatment, highest (lowest) rates of adverse events or toxicities.

A

regression approach has the flaw that regression models may fit the data well globally,
while simultaneously “smoothing” out the bumps in the response surface that PRIM
finds. The Framingham case study illustrates that the rules defining a box induced
by the algorithm readily translate into clinically meaningful subgroup definitions.
The PRIM algorithm is not free of disadvantages, however. The greatest disadvantage of the algorithm is that it is a greedy algorithm. Greedy algorithms make
the “best” local choice at each iteration, which may yield a final solution that is
sub-optimal–for a good discussion of this problem see Gutin et al. (2002). One
promising solution to this problem would be to build an ensemble learner using an
aggregation of bootstrapped PRIM models. However, such an ensemble model would
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obscure the interpretability of the rules defining boxes, making defining subgroups
more challenging. Additionally, the PRIM algorithm suffers from nominal covariates
dominating splits if large proportions of the data share the same factor level. For
example, in all three of the first induced Framingham boxes, “Sex” is used as the
second split criteria. In this instance, the candidate sub-boxes for removal for the
numerical covariates such as “Age” are based on removing 15% of the data (since
θ = 0.15 in our analysis), while the candidate sub-boxes for removal using the “Sex”
covariate contain roughly 50% of the data. Thus, the test statistics for comparing the
candidate sub-boxes based on factor levels of “Sex” are likely to be greater than for
those for “Age” by virtue of the choice of the algorithm parameter θ. One possible
way solution to this problem would be to build an ensemble learner that restricts the
number of covariates considered at each split. This approach would be similar to the
construction of random forests (Hastie et al., 2008).
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